In this prospective exploratory study of a mixed cohort of head and neck cancer patients, we compared the expression of serum immune proteins in two groups of patients: those with p16+ HNSCC and those with p16- HNSCC. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.